Prostate cancer Clinical Trials in Fayetteville, NC
As of June 2026, 1 paid clinical trial is recruiting for Prostate cancer in Fayetteville, North Carolina. Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Fayetteville
Filter results
1 clinical trial for Prostate cancer
·Clear filters·↓ Download CSVAbout research studies in Fayetteville
Fayetteville has approximately 42 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Top Research Study Locations in Fayetteville
Researchers run research studies in Fayetteville, NC at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Coastal Research Institute, LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 3 |
| Cross Creek Medical Clinic | Colitis, Ulcerative, Crohn's Disease, Inflammatory Bowel Diseases | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Cape Fear Valley Medical Center | Breast Cancer, Pain, Postoperative | 2 |
| Coastal Research Institute | MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction-associated Steatohepatitis | 2 |
| Coastal Research Institute - Fayetteville | Obesity or Overweight, Crohn's Disease, Ulcerative Colitis | 2 |
| Cross Creek Medical Clinic - Site Number: 8400057 | Ulcerative Colitis | 2 |
| Cross Creek Medical Clinic, PA | Systemic Lupus Erythematosus, Vulvovaginal Candidiases, Vulvovaginal Candidiasis (VVC) | 2 |
| Cross Creek Medical Clinic-Site Number: 8400057 | Crohn's Disease | 2 |
| Anthos Investigative Site 1048 | Atrial Fibrillation (AF) | 1 |
| Cape Fear Valley Health System | Anal Cancer, Bile Duct Cancer, Bladder Cancer | 1 |
| Cape Fear Valley Health System ( Site 0136) | Triple-Negative Breast Cancer | 1 |
| Cape Fear Valley Health System (Javara Inc.) | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| Cape Fear Valley Health Systems - Cancer Center | Breast Cancer | 1 |
| Care Access - Fayetteville | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| Carolina Institute for Clinical Research, LLC | Migraine | 1 |
| Carolina Rheumatology | Lumbar Spinal Stenosis, Sciatica Acute | 1 |
| Fayetteville VA Medical Center, Fayetteville, NC | Comorbid Post-Traumatic Stress Disorder and OCD, Obsessive Compulsive Disorder (OCD) | 1 |
| Fort Liberty | Brain Concussion | 1 |
| Ft. Bragg | Military Activity, Military Operations | 1 |
| Javara Inc. | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Vima Site #040 | Dystonia | 1 |
| WR-Carolina Institute for Clinical Research | Atrophic Vaginitis, Genitourinary Syndrome of Menopause, Lichen Planus of Vulva | 1 |
Active & Upcoming Studies in Fayetteville (2026)
Recruiting trials in Fayetteville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (7 active studies)
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study · Phase 3 · Eli Lilly and Company
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Cancer & tumors (4 active studies)
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence · Phase 3 · Stemline Therapeutics, Inc.
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) · Phase 3 · Merck Sharp & Dohme LLC
Cardiovascular (3 active studies)
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin · Phase 3 · AstraZeneca
Neurology & pain (2 active studies)
- Scheduled or As Needed Pain Regimen? · Phase 4 · Cape Fear Valley Health System
- Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects · Phase 3 · Pfizer
Common conditions studied in Fayetteville
- Crohn's Disease (4 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Ulcerative Colitis (3 active studies). Ulcerative colitis trials examine biologic therapies, S1P receptor modulators, and oral small molecules for steroid-sparing remission.
- MASH - Metabolic Dysfunction-Associated Steatohepatitis (2 active studies). Recruiting MASH - Metabolic Dysfunction-Associated Steatohepatitis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Obesity or Overweight (2 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- APOL1-Mediated Kidney Disease (1 active study). Kidney disease trials investigate SGLT-2 inhibitors, mineralocorticoid receptor antagonists, and novel antifibrotic therapies to slow progression.
Leading research sponsors in Fayetteville
- AstraZeneca
- Sanofi
- Boehringer Ingelheim
- Eli Lilly and Company
- 89bio, Inc.
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Fayetteville. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Fayetteville
Hipa.ai aggregates every recruiting study in Fayetteville from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Fayetteville?
There are approximately 42 recruiting clinical trials in Fayetteville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fayetteville pay participants?
Most recruiting trials in Fayetteville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fayetteville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fayetteville?
The most common conditions under active study in Fayetteville include Crohn's Disease (4), Breast Cancer (3), Ulcerative Colitis (3), MASH - Metabolic Dysfunction-Associated Steatohepatitis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fayetteville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fayetteville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fayetteville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fayetteville?
Recruiting research sites in Fayetteville include Coastal Research Institute, LLC, Cross Creek Medical Clinic, 89bio Clinical Study Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fayetteville right now?
The largest active categories in Fayetteville are Diabetes & metabolic (7), Cancer & tumors (4), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.